Anyone going to the Breast Cancer Symposium Sept in SF?
 

Link to the entire agenda:
http://www.asco.org/portal/site/ASCO...00ed730ad1RCRD

There is a session dedicated to Her 2 discussion:

<TABLE style="BORDER-RIGHT: #868687 1px solid; BORDER-LEFT: #868687 1px solid" height="100%" cellSpacing=0 cellPadding=0 width="100%" border=0 valign="top"><TBODY><TR><TD width=20></TD><TD vAlign=top><!--Chromeless Portlet Start--><!-- Begin Table: Breadcrumb --><TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD>



</TD></TR></TBODY></TABLE><!-- End Table: Breadcrumb --><!--Chromeless Portlet End--><!--br /--><!--Chromeless Portlet Start--><!--* File: AscoItemDetail.jsp** File Modifications:* DATE DEVELOPER CHANGE* -------- --------- -----------------------* 01-31-06 Henry Hsu Added Member-only check* 01-31-07 ASrivastav 1. Modified Member-only check logic* 2. Added logging to JSP* 3. Used ASCOAuthenticationUtil to check user group*-->

Program Agenda

<INPUT type=hidden name=sectionIdToBeShown> <TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD>


Saturday, September 8, 2007

7:00 AM – 8:00 AM
Breakfast Available and General Poster Session C

7:45 AM – 8:00 AM
Welcome

8:00 AM – 9:45 AM
General Session V: Local Regional Management
- Is Axillary Dissection Needed in Node (+) Breast Cancer?
- Is There a Role for Local Treatment in Metastatic Breast Cancer?
- Is There an Optimal Timing for Radiation Therapy and Reconstruction?
- Partial Breast Irradiation: Biological Underpinnings and Clinical Data
- Does Subtype and Genotype Influence Local Treatment Decisions?
- Can We Use Early Response Assessment to Guide Preoperative Therapy?
General Session VI: HER2 Positive Breast Cancer
- Biology of HER2 (+) Disease/Role of ER
- HER2 Testing
- What is the Role of Chemotherapy with Trastuzumab?
- Tyrosine-Kinase Inhibitors
- Other Anti-HER2 Agents
- Imaging and HER2 Therapy: Targeting and Response







</TD></TR></TBODY></TABLE>
</TD></TR></TBODY></TABLE>